In mice, the heart nearly quadruples in size from early preadolescence (postnatal day 10 [P10]) to puberty (P35) (Naqvi et al., 2014) . Because it is widely believed that mammalian cardiomyocytes (CMs) are incapable of replication after birth, it has been assumed that early postnatal heart growth is driven solely by CM hypertrophy. Our findings question this view and provide insights into how thyroid hormone may regulate an increase in CM number during preadolescence. Alkass et al. (2015) and Soonpaa et al. (2015) present evidence that conflicts with our conclusions; we believe that differences in experimental design and methodology could account for the discrepancy. Alkass et al. (2015) , using design-based stereology, concluded that the murine CM population does not increase during preadolescence. Their measurements of CM numbers ( Figure S1C in Alkass et al.) , when pooled into groups encompassing P5-P9 and P11-P100, show an 20% increase between the two developmental periods (p < 0.001), indicating a CM population expansion at some time after P9 (or early preadolescence). But the authors, based on comparisons of CM numbers on single days, conclude that there was no increase during preadolescence ( Figure 1E in Alkass et al.) . This conclusion may stem from the large variance in their data between P11 and P100, together with a low number of replicates. Given the reported SD of means (for CM numbers) between P11 and P100, and with three replicates, their study is underpowered to reliably refute even a 40% change in CM numbers.
In agreement with our findings, analysis of raw data from a study (Puente et al., 2014 ) that used cell disaggregation/counting protocols to determine the murine CM population (Figures 4G and 7I of Puente et al. [2014] , data kindly supplied by Hesham Sadek), showed an increase of 33% between P7 and P21 (p = 0.0396), and of 29% between P7 and P14 (p = 0.029) (Student's t test, twotailed).
Our counting method relies on similar tissue digestion/disaggregation efficiencies between hearts of different ages. To validate our findings, we calculated CM numbers in the heart by dividing total ventricular volume (occupied by CMs) by the average CM volume (Naqvi et al., 2014) , an approach independent of digestion efficiency. This also revealed an increase in CM numbers during preadolescence, supporting the numbers estimated by direct cell counting. Alkass et al. offer the unsupported assertion that apparent increases in the CM population are caused by variations in digestion efficiency between hearts of different ages, but this is refuted by our finding of markedly reduced CM numbers in mice of the same age when T3 biosynthesis is inhibited (Naqvi et al., 2014) . Design-based stereology, used by Alkass et al., relies on accurate delineation of CM boundaries over several tissue planes; it is ideal for nearly spherical neonatal CMs, but technically challenging when CMs become elongated and branched during preadolescence. Moreover, Alkass et al. randomly sampled only 1%-2% of the heart, which they assume to be homogeneous. We found that CMs undergoing mitosis and cytokinesis are present mainly in the subendocardium (Naqvi et al., 2014) , indicating cellular heterogeneity in thyroid hormone response. Hence, random assessment of a few sites, as in Alkaas et al., is likely to increase estimation errors. Together with analysis of only a few hearts at each age, this could produce errors that are reflected in a very high variance in their CM numbers, and thereby obscure biologically meaningful increases in CM numbers during preadolescence.
Alkass et al. and Soonpaa et al. were unable to detect mitoses in preadolescent CMs. We thus sent unprocessed murine heart sections to Richard Harvey's laboratory (Victor , with no Aurora B-positive cells evident in the LV of the P10 heart (A). CMs are labeled with cardiac troponin T (cTNT) (green) and nuclei are labeled with DAPI (blue). Arrows show some Aurora Bpositive CMs. Experimental procedures used for immunohistochemistry were essentially as described (Naqvi et al., 2014) . The Aurora B antibody (Abcam, ab 2254), supplied as a 1-mg/ml solution, was used at a dilution of 1:50. Sections were prepared and antibodies provided by the Graham laboratory. Immunohistochemical staining was performed in a blinded manner by the Harvey laboratory.
Chang Cardiac Research Institute).
Blinded experiments indicated nuclear Aurora B labeling (which marks mitotic cells) in hearts at P2, P14 (harvested 9 p.m.), and P15, but not P10 or P18 ( Figure 1A and 1B and data not shown), consistent with Naqvi et al. (2014) . Soonpaa et al. declined our offer of unprocessed tissue sections from Naqvi et al. (2014) for independent validation. Alkass et al. dispute that Aurora B + nuclei ( Figure 3B in Naqvi et al. [2014] ) are in CMs. However, we showed unambiguous sarcomeric a-myosin heavy chain labeling in isolated Aurora B + P15 CMs ( Figure 3G in Naqvi et al. [2014] ), which is also evident in a very high-resolution micrograph of a P15 heart section ( Figure S1 ). These data confirm mitosis in these CMs. Both Alkass et al. and Soonpaa et al. invoke a discrepancy between our estimate of the number of new CMs born at P15 (direct counting) and estimates of the percentage of CMs that have undergone a new S-phase (BrdU labeling). Our numbers are similar to those independently observed by Murray et al. (2015) using a protocol like ours and are consistent with extensive other data we have published (Naqvi et al., 2014) . We suggest that S-phase CMs are underestimated by the methods used by Alkass et al. and Soonpaa et al. We are not surprised that a BrdU pulse on P14 labels only 3%-5% of CMs (Naqvi et al., 2014; Murray et al., 2015) ; in rodents the time of tracer clearance from blood ranges from 0.5 to 1 hr, short compared with the length of S-phase (Duque and Rakic, 2011) , and S-phase in CMs may not be synchronized. While continuous BrdU infusion avoids this limitation, the anti-proliferative effects of BrdU/ EdU could depress CM division, and toxicity may increase death of labeled cells. Thus the BrdU/EdU labeling index, after pulse or continuous administration, is not an infallible indicator of the extent of cell replication (Duque and Rakic, 2011) . CM numbers after birth vary strikingly with litter size (Bai et al., 1990) , and variations in animal husbandry, litter size, or gender could affect both the timing and time-to-peak of environmentally programmed hormonal influences on CM numbers; thus we have analyzed only male C57BL/6J litters of 6-7 pups with confirmed birth dates.
In summary, the findings of Alkass et al. and Soonpaa et al. do not refute our multiple lines of evidence indicating an increase in the CM population during preadolescence (Naqvi et al., 2014) . In support of our findings, Wulfsohn et al. (2004) , using stereology, found a doubling of CM numbers in rats from P25-P125, and Mollova et al. (2013) , also using stereology, found a 3.4-fold increase in human CM numbers from 1-20 years. These data, and our evidence for markers of CM mitoses, mitotic figures, acute decreases in cell volume consistent with CM replication, and BrdU labeling, provide compelling evidence for CM proliferation during preadolescence (Naqvi et al., 2014) . Finally, Mollova et al. (2013) and Bergmann et al. (2009) found that most human CMs are formed during the first 10 years of life-that is, in preadolescence-which is the key finding of Naqvi et al. (2014) .
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